Study Stopped
IRB had concerns about study; terminated
Baby Bump Lifestyle Intervention Supplement Study
Baby BLISS
1 other identifier
interventional
4
1 country
1
Brief Summary
The overall purpose of this study is to examine how natural supplements can mediate the effects of stress on fetal development during pregnancy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 19, 2018
CompletedFirst Posted
Study publicly available on registry
November 23, 2018
CompletedStudy Start
First participant enrolled
March 21, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2019
CompletedFebruary 20, 2020
February 1, 2020
8 months
November 19, 2018
February 18, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
lower blood stress markers via venous draw
We hypothesize that the addition of nutrients during gestation will decrease the levels of stress hormones/reactants in pregnant women who are at high risk for stressful pregnancies.
9 months
Study Arms (2)
Placebo
PLACEBO COMPARATORplacebo supplement
Supplement
EXPERIMENTALactual supplement
Interventions
Supplement will be given to this group to take daily for 8 weeks
Eligibility Criteria
You may qualify if:
- Pregnant woman presenting to her first obstetrical visit for this pregnancy
- Must be in the first trimester (\<13 weeks)
- years or older
- High-stress levels as measured by the Perceived Stress Level Questionnaire
- Must be a single pregnancy (e.g. not twins, triplets, etc.)
You may not qualify if:
- Diabetes (types 1 and 2)
- Diagnosis of gestational diabetes in prior pregnancy
- Hyperemesis gravidarum or severe morning sickness that interferes with supplement intake
- Major medical illnesses including but not limited to: malabsorption syndromes (Celiac's disease, Crohn's, Ulcerative Colitis), Systemic Lupus Erythematosus and other major autoimmune conditions
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
SUNY Buffalo
Buffalo, New York, 14214, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
November 19, 2018
First Posted
November 23, 2018
Study Start
March 21, 2019
Primary Completion
November 30, 2019
Study Completion
November 30, 2019
Last Updated
February 20, 2020
Record last verified: 2020-02
Data Sharing
- IPD Sharing
- Will not share